Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit

NCT04853927 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor to focus on hospitalised patients

Conditions

Covid19
SARS (Severe Acute Respiratory Syndrome)

Interventions

DRUG: Proxalutamide
DRUG: Placebo

Sponsor

Applied Biology, Inc.